Related Experiment Video
Updated: Aug 5, 2026

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
Published on: August 31, 2016
Hematopoietic stem cell transplantation between red cell incompatible donor-recipient pairs
1Adult Allogeneic Stem Cell Transplant Program, Hackensack University Medical Center, Hackensack, NJ 07601, USA.
Red blood cell transplantation between different donors and recipients is possible with careful management of immunohematological risks. Addressing hemolysis and delayed red blood cell recovery is crucial for successful outcomes.
Area of Science:
- Transfusion Medicine
- Immunology
- Hematology
Background:
- Transplantation involving red blood cells with differing antigen profiles between donor and recipient presents unique challenges.
- Understanding the immunohematological implications is key to mitigating risks.
- Potential complications include hemolysis and delayed red blood cell engraftment.
Purpose of the Study:
- To assess the feasibility of red blood cell transplantation between antigen-disparate donors and recipients.
- To identify and address the risks associated with such transplants, particularly hemolysis and engraftment delays.
- To provide guidance on managing immunohematological consequences for successful transplantation.
Main Methods:
- Review of clinical data and immunohematological assessments in red cell-transplant recipients.
- Analysis of immediate and delayed post-transplant complications, focusing on hemolysis.
- Monitoring of red blood cell recovery and engraftment timelines.
Main Results:
- Transplantation between red cell-disparate donors and recipients is feasible.
- Minimal increase in transplantation risks observed when immunohematological factors are managed.
- Immediate and delayed hemolysis represent significant risks requiring careful management.
- Delayed recovery of red blood cells is a potential consequence for some recipients.
Conclusions:
- Red blood cell transplantation across antigen disparities is achievable.
- Proactive management of hemolysis and delayed engraftment is essential for patient safety and transplant success.
- Consideration of immunohematological consequences minimizes transplant-related risks.
More Related Videos
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
03:40Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
Published on: December 8, 2023
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction